We argue for the possibility that the ectopic expression of MEILB2, or its fusion protein, in cancer cells can perturb the intrinsic BRCA2 function through direct binding, thus contributing to cancer development by disturbing the mitotic HR pathway. Here, BRCA2 is linked to cancer.